当前位置: X-MOL 学术J. Am. Acad. Dermatol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Real-world treatment outcomes of systemic treatments for moderate-to-severe atopic dermatitis in children aged less than 12 years: 2-year results from PEDIatric STudy in Atopic Dermatitis
Journal of the American Academy of Dermatology ( IF 12.8 ) Pub Date : 2024-10-09 , DOI: 10.1016/j.jaad.2024.09.046
Amy S. Paller MD, Marjolein de Bruin-Weller MD, Danielle Marcoux MD, Eulalia Baselga MD, Vania Oliveira de Carvalho MD, Ledit R.F. Ardusso MD, Suzanne G.M.A. Pasmans MD, Mirna Toledo-Bahena MD MSc, Cory Rubin MD, Joel C. Joyce MD, Lara Wine Lee MD PhD, Bryan Adams PhD, Rajan Gupta PhD, Marius Ardeleanu MD, Annie Zhang MD

The arrival of biologics and small-molecule therapies (eg Janus kinase inhibitors) changed atopic dermatitis treatment, but older systemic treatments continue to be prescribed.

中文翻译:


12 岁以下儿童中度至重度特应性皮炎全身治疗的真实世界治疗结果:特应性皮炎 PEDIatric STudy 的 2 年结果



生物制剂和小分子疗法(如 Janus 激酶抑制剂)的到来改变了特应性皮炎的治疗,但旧的全身治疗仍在继续。
更新日期:2024-10-09
down
wechat
bug